Form 4: Hims & Hers CCO Sells Shares After Option Exercise

Hims & Hers Health, Inc. Chief Commercial Officer Michael Chi exercised stock options and subsequently sold 250 shares of Class A Common Stock on October 1, 2025, under a Rule 10b5-1 plan.

Summary

• Michael Chi, Chief Commercial Officer of Hims & Hers Health, Inc., executed a transaction involving the company's Class A Common Stock.
• On October 1, 2025, Chi acquired 250 shares of Class A Common Stock by exercising stock options at a price of $11.53 per share.
• Immediately following the exercise on the same date, Chi sold 250 shares of Class A Common Stock at a price of $56.00 per share.
• These transactions were conducted pursuant to a Rule 10b5-1 trading plan, which was adopted by Chi on March 4, 2025.
• After these reported transactions, Michael Chi directly beneficially owns 291,439 shares of Class A Common Stock.
• Chi also holds 47,106 derivative securities in the form of stock options (right to buy) after the reported transactions.
• The options are subject to a service-based vesting requirement, with 1/48th of the options vesting monthly, beginning on April 1, 2023, over a 4-year period.

Sentiment

Score: 6

Explanation: The transaction represents a routine, pre-planned exercise of stock options and subsequent sale of a small portion of shares by a Chief Commercial Officer, indicating the executive is monetizing vested compensation. The pre-arranged nature under a Rule 10b5-1 plan mitigates concerns about opportunistic insider selling, leading to a slightly positive sentiment regarding corporate governance and executive compensation structure.

Positives

• The transaction was executed under a pre-arranged Rule 10b5-1 trading plan, which indicates a planned monetization of vested compensation rather than opportunistic selling.
• The Chief Commercial Officer realized a significant profit from the option exercise and sale, with shares acquired at $11.53 and sold at $56.00.

Negatives

• An insider sale, even if pre-planned, represents a disposition of shares by a key executive.

Future Outlook

The filing indicates that the reporting person has an ongoing Rule 10b5-1 trading plan, suggesting potential future pre-scheduled transactions. The remaining stock options will continue to vest monthly until fully satisfied.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction and does not provide specific insights into broader industry trends or competitive positioning for Hims & Hers Health, Inc. It reflects an executive's compensation realization within the healthcare technology sector.

Stakeholder Impact

• Shareholders: The sale of 250 shares is a very small volume and is unlikely to have a material impact on the company's stock price or overall shareholder value.
• Employees (Executive): The transaction allows the Chief Commercial Officer to realize value from their vested equity compensation, which is a positive for executive retention and motivation.

Next Steps

• Continued vesting of remaining stock options, with 1/48th vesting monthly from April 1, 2023.
• Potential future transactions under the Rule 10b5-1 trading plan adopted on March 4, 2025.

Key Dates

Keywords

Hims & Hers Health, HIMS, Insider Trading, Form 4, Stock Option Exercise, Share Sale, Rule 10b5-1 Plan, Chief Commercial Officer, Michael Chi